The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · Cited by 9,198
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
King, M. T. (1996) · Quality of Life Research · doi:10.1007/bf00439229 · Cited by 666
Self-citationCocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0107 · Cited by 658
Self-citationCella, D., Hahn, E. A., & Dineen, K. (2002) · Quality of Life Research · doi:10.1023/a:1015276414526 · Cited by 523
Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population
Schwarz, R., & Hinz, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00447-0 · Cited by 503
Helena Michelson, C. B. (2000) · Acta Oncologica · doi:10.1080/028418600750013384 · Cited by 379
Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1188 · Cited by 368
Self-citationInterpreting clinically significant changes in patient‐reported outcomes
Ringash, J., O'Sullivan, B., Bezjak, A., & Redelmeier, D. A. (2007) · Cancer · doi:10.1002/cncr.22799 · Cited by 305
Cited by
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706450 · Cited by 3,294
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Ray-Coquard, I., Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Mäenpää, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911361 · Cited by 2,055
Harrington, K. J., Ferris, R. L., Blumenschein, G., Colevas, A. D., Fayette, J., Licitra, L., Kasper, S., Even, C., Vokes, E. E., Worden, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30421-7 · Cited by 428
Self-citationBasch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA · doi:10.1001/jama.2022.9265 · Cited by 413
Galle, P. R., Finn, R. S., Qin, S., Ikeda, M., Zhu, A. X., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00151-0 · Cited by 375
Giesinger, J. M., Loth, F. L. C., Aaronson, N. K., Arraras, J. I., Caocci, G., Efficace, F., Groenvold, M., van Leeuwen, M., Petersen, M. A., Ramage, J., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.10.003 · Cited by 373
Siva, S., Bressel, M., Murphy, D. G., Shaw, M., Chander, S., Violet, J., Tai, K. H., Udovicich, C., Lim, A., Selbie, L., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.06.004 · Cited by 322
Stephenson, C. M., Levin, R. D., Spector, T., & Lis, C. G. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2179-9 · Cited by 264
Andre, T., Amonkar, M., Norquist, J. M., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C. J. A., Smith, D., Garcia-Carbonero, R., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00064-4 · Cited by 209
The role of vitamin C in the treatment of pain: new insights
Carr, A. C., & McCall, C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1179-7 · Cited by 160
The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life
Carr, A. C., Vissers, M. C. M., & Cook, J. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00283 · Cited by 104
Marschner, N., Zacharias, S., Lordick, F., Hegewisch-Becker, S., Martens, U., Welt, A., Hagen, V., Gleiber, W., Bohnet, S., Kruggel, L., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0643 · Cited by 90
Jeppesen, S. S., Bentsen, K. K., Jørgensen, T. L., Holm, H. S., Holst-Christensen, L., Tarpgaard, L. S., Dahlrot, R. H., & Eckhoff, L. (2021) · Acta Oncologica · doi:10.1080/0284186x.2020.1830169 · Cited by 61
Dennett, A. M., Sarkies, M., Shields, N., Peiris, C. L., Williams, C., & Taylor, N. F. (2021) · Journal of Physiotherapy · doi:10.1016/j.jphys.2020.12.008 · Cited by 44
Koinig, K. A., Arnold, C., Lehmann, J., Giesinger, J., Köck, S., Willenbacher, W., Weger, R., Holzner, B., Ganswindt, U., Wolf, D., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3950 · Cited by 34
Liu, Y. J., Schandl, A., Markar, S., Johar, A., & Lagergren, P. (2021) · BJS Open · doi:10.1093/bjsopen/zraa038 · Cited by 32
Delforge, M., Patel, K., Eliason, L., Dhanda, D., Shi, L., Guo, S., Marshall, T. S., Arnulf, B., Cavo, M., Nooka, A., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00005-x · Cited by 31
Nielsen, A. W. M., Lundorff, M., Nielsen, H. M., Alsner, J., Vrou Offersen, B., Kristensen, M. H., & Zachariae, R. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1981550 · Cited by 22
Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing
Schuler, M. K., Trautmann, F., Radloff, M., Schmädig, R., Hentschel, L., Eberlein-Gonska, M., Petzold, T., Vetter, H., Oberlack, S., Ehninger, G., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3163-9 · Cited by 10
Metadata
- Authors
- Cocks, K., King, M. T., Velikova, G., de Castro, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 48
- Issue
- 11
- Pages
- 1713-1721
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2018304470
- Cited by
- 552
- References
- 18
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
